| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;59:196-200
© 1995 The Society of Thoracic Surgeons
Department of Thoracic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Accepted for publication August 25, 1994.
* Address reprint requests to Dr Massard, Department of Thoracic Surgery, Hôpitaux Universitaires de Strasbourg, F-67091 Strasbourg, France.
From January 1, 1978 to December 31, 1992, 37 patients underwent a completion pneumonectomy after a previous lobectomy (36 men and 1 woman; mean age, 60 years; range, 41 to 77 years). These account for 4.8% of 758 pneumonectomies. The purpose of the present study was to evaluate the operative results of completion pneumonectomy and long-term survival in patients with bronchogenic cancer. The initial lung resection had been performed for primary bronchogenic cancer in 23, metastatic thyroid adenocarcinoma in 1, and benign diseases in 13 (tuberculosis in 11, aspergilloma in 1, and bronchiectasis in 1). Completion pneumonectomy was required for bronchogenic cancer in 32 (15 stage I, 6 stage II, 11 stage III). One patient had relapsing metastatic thyroid carcinoma, 2 had bronchiectasis, and 2 had a venous infarction after lobectomy. Four patients (10.8%) died perioperatively of the following causes: I fatal intraoperative bleeding, 1 fatal postoperative bleeding, 1 pneumonia, and 1 malignant hypercalcemia. Median operative blood loss was 1,000 mL, and 19 patients experienced bleeding exceeding 1,000 ml. (51%). Six patients had intraoperative vascular injury. Nonfatal surgical complications occurred in 9 patients (24%%), including 5 clotted hemothoraces, 3 empyemas, and 1 bronchopleural fistula. Four patients had medical complications (2 pulmonary edemas, 1 sinus tachycardia, and 1 unexplained fever). Twenty-three had an uneventful straightfoward recovery (62%). The 32 patients with bronchogenic cancer were followed up until date of death or July 1, 1993. Overall 5-year survival was 44.5% (59.7% for stage I, 41.6% for stage II, and 21.2% for stage III). We conclude that there is an increased operative risk after completion pneumonectomy; however, this risk is acceptable with respect to long-term survival.
This article has been cited by other articles:
|
|
 |
|
  O. Chataigner, E. Fadel, B. Yildizeli, A. Achir, S. Mussot, D. Fabre, O. Mercier, and P. G. Dartevelle Factors affecting early and long-term outcomes after completion pneumonectomy Eur J Cardiothorac Surg, May 1, 2008; 33(5): 837 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Jungraithmayr, J. Hasse, M. Olschewski, and E. Stoelben Indications and results of completion pneumonectomy Eur J Cardiothorac Surg, July 1, 2004; 26(1): 189 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Guggino, C. Doddoli, F. Barlesi, P. Acri, B. Chetaille, P. Thomas, R. Giudicelli, and P. Fuentes Completion pneumonectomy in cancer patients: experience with 55 cases Eur J Cardiothorac Surg, March 1, 2004; 25(3): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Miller, C. Deschamps, G. D. Jenkins, A. Bernard, M. S. Allen, and P. C. Pairolero Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity Ann. Thorac. Surg., September 1, 2002; 74(3): 876 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Terzi, A. Lonardoni, G. Falezza, P. Scanagatta, A. Santo, G. Furlan, and F. Calabro Completion pneumonectomy for non-small cell lung cancer: experience with 59 cases Eur J Cardiothorac Surg, July 1, 2002; 22(1): 30 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fujimoto, G. Zaboura, S. Fechner, L. Hillejan, T. Schroder, A. Marra, T. Krbek, M. Hinterthaner, D. Greschuchna, and G. Stamatis Completion pneumonectomy: Current indications, complications, and results J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 484 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Massard, X. Ducrocq, M. Beaufigeau, S. Elia, R. Kessler, J.-F. Herve, and J.-M. Wihlm Lung cancer following previous extrapulmonary malignancy Eur J Cardiothorac Surg, November 1, 2000; 18(5): 524 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Massard, R. Kessler, B. Gasser, X. Ducrocq, S. Elia, S. Elia, S. Gouzou, and J.-M. Wihlm Local control of disease and survival following bronchoplastic lobectomy for non-small cell lung cancer Eur J Cardiothorac Surg, September 1, 1999; 16(3): 276 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Regnard, P. Icard, P. Magdeleinat, B. Jauffret, E. Fares, and P. Levasseur COMPLETION PNEUMONECTOMY: EXPERIENCE IN EIGHTY PATIENTS J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1095 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gharagozloo, G. Trachiotis, A. Wolfe, K. J. DuBree, and J. L. Cox PLEURAL SPACE IRRIGATION AND MODIFIED CLAGETT PROCEDURE FOR THE TREATMENT OF EARLY POSTPNEUMONECTOMY EMPYEMA J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 943 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Muysoms, A. Brutel de la Riviere, J. J. Defauw, K. M. Dossche, P. J. Knaepen, H. A. van Swieten, and J. M.M. van den Bosch Completion pneumonectomy: analysis of operative mortality and survival Ann. Thorac. Surg., October 1, 1998; 66(4): 1165 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. H. John, P. G. Magee, A. J. Wood, and C. T. Lewis Clearance after lobectomy and the role of completion pneumonectomy Ann. Thorac. Surg., August 1, 1995; 60(2): 487 - 487. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
